Huntington's disease

被引:32
作者
Ross, CA
Margolis, RL
机构
[1] Johns Hopkins Univ, Sch Med, Div Neurobiol, Mol Neurobiol Lab,Dept Psychiat, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Div Neurobiol, Lab Genet Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Huntington; trinucleotide repeat; glutamine; neurodegeneration; movement; psychiatric;
D O I
10.1016/S1566-2772(00)00014-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
dHuntington's disease (HD) is an autosomal dominant progressive neuropyschiatric disorder, characterized h abnormalities of movement, emotion and cognition. The most important pathologgical feature is selective neuronal loss, primarily in the striatum and cerebral cortex. HD is caused by the expansion of a CAG trinucleotide repeat in the gene encoding humingtin. The expanded repeat encodes an abnormally long polyglutamine tract, and many lines of evidence no strongly suggest that this mutation is neurotoxic. In this review, we first detail the clinical, genetic and pathological features of HID. We then describe how clues from neurotoxicological, biochemical, cell, transgenic mouse, and invertebrate models of HD lead to a multifactored model of HD pathogenesis,. We Conclude h discussing how the model of HD serves as a guide to the development of rational therapeutics for this devastating disease. (C) 2001 Association for Research in Nervous and Mental Disease. All rights reserved.
引用
收藏
页码:142 / 152
页数:11
相关论文
共 103 条
  • [21] Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity
    Ellerby, LM
    Andrusiak, RL
    Wellington, CL
    Hackam, AS
    Propp, SS
    Wood, JD
    Sharp, AH
    Margolis, RL
    Ross, CA
    Salvesen, GS
    Hayden, MR
    Bredesen, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8730 - 8736
  • [22] Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron
    Faber, PW
    Alter, JR
    MacDonald, ME
    Hart, AC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 179 - 184
  • [23] Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154
  • [24] Assessment of coenzyme Q10 tolerability in Huntington's disease
    Feigin, A
    Kieburtz, K
    Como, P
    Hickey, C
    Claude, K
    Abwender, D
    Zimmerman, C
    Steinberg, K
    Shoulson, I
    [J]. MOVEMENT DISORDERS, 1996, 11 (03) : 321 - 323
  • [25] Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
    Ferrante, RJ
    Andreassen, OA
    Jenkins, BG
    Dedeoglu, A
    Kuemmerle, S
    Kubilus, JK
    Kaddurah-Daouk, R
    Hersch, SM
    Beal, MF
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (12) : 4389 - 4397
  • [26] SELECTIVE SPARING OF A CLASS OF STRIATAL NEURONS IN HUNTINGTONS-DISEASE
    FERRANTE, RJ
    KOWALL, NW
    BEAL, MF
    RICHARDSON, EP
    BIRD, ED
    MARTIN, JB
    [J]. SCIENCE, 1985, 230 (4725) : 561 - 563
  • [27] HUNTINGTONS-DISEASE - 2 FAMILIES WITH DIFFERING CLINICAL-FEATURES SHOW LINKAGE TO THE G8 PROBE
    FOLSTEIN, SE
    PHILLIPS, JA
    MEYERS, DA
    CHASE, GA
    ABBOTT, MH
    FRANZ, ML
    WABER, PG
    KAZAZIAN, HH
    CONNEALLY, PM
    HOBBS, W
    TANZI, R
    FARYNIARZ, A
    GIBBONS, K
    GUSELLA, J
    [J]. SCIENCE, 1985, 229 (4715) : 776 - 779
  • [28] Folstein SE, 1989, HUNTINGTONS DIS DISO
  • [29] Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease
    Furtado, S
    Suchowersky, O
    Rewcasle, NB
    Graham, L
    Klimek, ML
    Garber, A
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (01) : 132 - 136
  • [30] Huntingtin aggregation monitored by dynamic light scattering
    Georgalis, Y
    Starikov, EB
    Hollenbach, B
    Lurz, R
    Scherzinger, E
    Saenger, W
    Lehrach, H
    Wanker, EE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) : 6118 - 6121